PMID: 3756822Nov 1, 1986Paper

Carcinoma of the fallopian tube. Management and sites of failure

Cancer
E H McMurrayA Galakatos

Abstract

Thirty patients with adenocarcinoma of the fallopian tube, treated between 1950 and 1981, were studied. Median age was 55 years, and mean parity was 1.3. Bleeding or discharge occurred as a presenting complaint in 47% of patients, abdominal distention or mass in 50%, and pain in 30%. Lesions were staged using a system analogous to the International Federation of Gynecology and Obstetrics (FIGO) classification for ovarian carcinoma. Nine patients had Stage I disease; 11, Stage II; 7, Stage III; and 3, Stage IV. Histologic differentiation was Grade 1 in 39% of the patients, Grade 2 in 18%, and Grade 3 in 43%. Primary surgical treatment consisted of total abdominal hysterectomy and bilateral salpingectomy in 70% of the patients; 23% had more extensive surgery, whereas 13% had less extensive surgery. Three patients with Stage I tumors were treated with surgery alone, and the remainder received postoperative radiation, chemotherapy, or both. Survival was unrelated to grade, but highly dependent upon stage. Survival at 5 years was 56% for Stage I, 27% for Stage II, 14% for Stage III, and 0% for Stage IV. Four of five patients treated after surgery with a combination of cisplatin, doxorubicin, and cyclophosphamide (PAC) survived at le...Continue Reading

References

Jun 1, 1977·Gynecologic Oncology·S R HendersonJ H Rudolph
Feb 1, 1978·The Surgical Clinics of North America·A Sedlis
Jul 15, 1976·American Journal of Obstetrics and Gynecology·G E Kinzel
Sep 1, 1971·American Journal of Obstetrics and Gynecology·J G Boutselis, J N Thompson
Aug 1, 1971·Cancer·H M Schiller, S G Silverberg
Jun 1, 1969·Cancer·I Fogh
Oct 1, 1984·Gynecologic Oncology·G L EddyD M Gershenson
Jun 1, 1982·Gynecologic Oncology·J A Roberts, S Lifshitz
Sep 15, 1981·American Journal of Obstetrics and Gynecology·H K Tamimi, D C Figge
Nov 1, 1981·British Journal of Obstetrics and Gynaecology·K S RajuE Wiltshaw
Jan 1, 1950·American Journal of Obstetrics and Gynecology·C Y HUA T HERTIG

❮ Previous
Next ❯

Citations

Jan 1, 1994·Archives of Gynecology and Obstetrics·M KleinH Kucera
Jan 1, 1993·Archives of Gynecology and Obstetrics·M KleinA Beck
Jun 27, 1998·Medical Oncology·A C Hellström
Sep 30, 2010·International Journal of Clinical Oncology·Yu-Jin KooJung-Eun Mok
Dec 1, 1994·European Journal of Obstetrics, Gynecology, and Reproductive Biology·L BorghiR M Fortini
Apr 30, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·E KalampokasI Tourountous
Sep 24, 2004·Gynecologic Oncology·Takao HidakaShigeru Saito
Jun 7, 2000·Cancer Letters·A C RosenA Reiner
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·M KleinA Rainer
Jan 9, 1998·International Journal of Radiation Oncology, Biology, Physics·A H WolfsonM E Randall
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A C RosenA Reiner
Jun 2, 2001·Journal of Epidemiology and Biostatistics·A P HeintzS Pecorelli
Apr 1, 1997·American Journal of Clinical Oncology·G CormioA Lissoni
Jan 1, 1996·The American Journal of Surgical Pathology·W ZhengS A Hoda
Jan 22, 2002·Current Opinion in Obstetrics & Gynecology·Angiolo Gadducci
Mar 30, 2005·Obstetrical & Gynecological Survey·T V AjithkumarO S Ashokkumar
Aug 12, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M M InalS Tinar
Mar 6, 1999·The Journal of Obstetrics and Gynaecology Research·S TakeuchiN Toyoda
Oct 26, 1999·The Journal of Obstetrics and Gynaecology Research·J W KimJ H Han
Sep 1, 1990·British Journal of Obstetrics and Gynaecology·H GurneyD Crowther
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S BatraJ S Wynn
Apr 1, 1997·Acta Obstetricia Et Gynecologica Scandinavica·G CormioC Mangioni
Jan 1, 2011·Case Reports in Obstetrics and Gynecology·N A HealyK J Sweeney
Jun 12, 2009·Medicinski pregled·Ljiljana Mladenović-Segedi
Mar 1, 1996·Acta Obstetricia Et Gynecologica Scandinavica·B JereczekA Kobierska
Nov 3, 2005·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·N L ClaytonL Hirschowitz
Oct 27, 2007·Gynecologic Oncology·Sherri L StewartFrances Michaud
Jul 29, 2011·The Journal of Obstetrics and Gynaecology Research·Ihab ElsokkariMorteza Aghmesheh
Aug 11, 1991·Gynecologic Oncology·R R BarakatW J Hoskins
Mar 1, 1989·Gynecologic Oncology·M KinoshitaT Matsuda
Mar 1, 1989·Gynecologic Oncology·C R HarrisonB U Sevin
Nov 1, 1990·Gynecologic Oncology·F W Abdul-KarimJ T Makley
Mar 1, 1991·Gynecologic Oncology·H G MuntzA F Fuller
Jul 21, 2009·Gynecologic Oncology·D PectasidesT Economopoulos
Jan 4, 2001·Gynecologic Oncology·M L GemignaniR R Barakat
Dec 15, 1990·Cancer·P G RoseY Tsukada
Jan 1, 1997·Acta Oncologica·F Dubecq-PrinceteauY le Charpentier
Apr 20, 2004·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Rupa N MaitraPeter Dady
Jul 2, 2004·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·N Haratz-RubinsteinD Gal
Sep 29, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M. M. VaughanM. J. Weitzer
Apr 4, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A ObermairL Perrin
Sep 5, 2006·The Oncologist·Dimitrios PectasidesTheofanis Economopoulos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved